Author/Authors :
Trevisani, Viola Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy , Bruzzi, Patrizia Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy , Filomena Madeo, Simona Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy , Cattini, Umberto Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy , Lucaccioni, Laura Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy , Predieri, Barbara Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy , Iughetti, Lorenzo Department of Medical and Surgical Sciences of the Mother Children and Adults - University of Modena and Reggio Emilia, Modena, Italy
Abstract :
Due to the current COVID-19 pandemic, worldwide population’s lifestyle has changed dra-matically, causing psychosocial consequences. Patients presenting a preexisting chronic condition, as Type 1 Diabetes (T1D), are the ones suffering the most from this situation. Moreover, people affected by diabetes are the ones with the worst prognosis, if infected by SARS-CoV-2. We analyzed why patients with T1D were poorly represented between the subjects hospitalized for COVID-19 and why the cases of diabetic ketoaci-dosis (DKA) were fewer and more severe compared with the past years. Furthermore, literature has showed how patients of all ages with T1D did not experience a deterioration in their glucose control throughout the lockdown. Among other causes, this is also due to the surging use of telemedicine. Finally, we tried to un-derstand how the coronavirus tropism for endocrine tissues could influence the future epidemiology of T1D, focusing on the effects they have on pancreatic β-cells.
Keywords :
COVID19 , Type 1 Diabetes , Children , Telemedicine
